Suppr超能文献

[抗纤维蛋白溶解疗法掩护下延迟手术治疗动脉瘤性脑膜出血的前瞻性试验]

[Prospective trial of treating aneurysmal meningeal hemorrhage by delayed operation under cover of antifibrinolytic therapy].

作者信息

Irthum B, Chazal J, Commun C, Chabannes J, Janny P

出版信息

Neurochirurgie. 1986;32(2):122-8.

PMID:3523271
Abstract

Seventy patients with subarachnoid haemorrhage due to ruptured intracranial aneurysms were managed by delayed intervention (third week) along with the prescription of antifibrinolytic drugs (tranexamic acid 6 g/daily). During the pre-operative period, 41 patients stayed in the same clinical status as on admission or improved, whereas 29 deteriorated due to rebleeding (4 cases), vasospasm (18 cases), large hematoma (4 cases), hydrocephalus (2 cases) and postarteriographic accident (1 case). Clipping the aneurysm was finally achieved in 42 patients only; with 3 deaths, 3 severe sequellae, 8 light handicaps, and 28 patients considered as cured with returning to previous occupations. As far as the whole series is concerned, these results yield a 38.5% rate of mortality, 20% morbidity, and 41.5% recovery. It is concluded that 1) Tranexamic acid was effective in reducing the risk or rebleeding, 2) Third week delayed intervention associated with this drug significantly reduced the operative mortality, but probably favoured vasospasm, and finally had no beneficial effect on the overall results concerning the entire series of patients.

摘要

70例因颅内动脉瘤破裂导致蛛网膜下腔出血的患者接受了延迟干预(第三周),同时开具了抗纤维蛋白溶解药物(氨甲环酸6克/天)。在术前期间,41例患者的临床状态与入院时相同或有所改善,而29例患者因再出血(4例)、血管痉挛(18例)、巨大血肿(4例)、脑积水(2例)和动脉造影术后意外(1例)而病情恶化。最终仅42例患者成功夹闭动脉瘤;其中3例死亡,3例出现严重后遗症,8例轻度残疾,28例患者被视为治愈并恢复原工作。就整个系列而言,这些结果导致死亡率为38.5%,发病率为20%,恢复率为41.5%。结论为:1)氨甲环酸在降低再出血风险方面有效;2)与该药物相关的第三周延迟干预显著降低了手术死亡率,但可能促进了血管痉挛,最终对整个系列患者的总体结果没有有益影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验